Cargando…

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common malignant neoplasms. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) plays a key role in the lipid remodelling and is correlated with various neoplasms. Nonetheless, the biological functions and molecular mechanisms of LPCA...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Rong-Quan, Li, Jian-Di, Du, Xiu-Fang, Dang, Yi-Wu, Yang, Lin-Jie, Huang, Zhi-Guang, Liu, Li-Min, Liao, Liu-Feng, Yang, Hong, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380368/ https://www.ncbi.nlm.nih.gov/pubmed/34419067 http://dx.doi.org/10.1186/s12935-021-02130-4

Ejemplares similares

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments
por: Chen, Zu‐Xuan, et al.
Publicado: (2023)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2023)

Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis
por: Liu, Ran, et al.
Publicado: (2023)

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020)

Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues
por: Liu, Yongru, et al.
Publicado: (2015)

LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
por: Xiao, Yi, et al.
Publicado: (2020)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Wang, Lei, et al.
Publicado: (2021)

Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma
por: Liu, Xin-rui, et al.
Publicado: (2016)

CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma
por: Chen, Ruo, et al.
Publicado: (2016)

Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway: Tumor-promoting effect of LPCAT1 in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2022)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression
por: Wan, Jian, et al.
Publicado: (2021)

Carcinogenic effect of adenylosuccinate lyase (ADSL) in prostate cancer development and progression through the cell cycle pathway
por: Liao, Jinling, et al.
Publicado: (2021)

Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells
por: Yuan, Zhaohu, et al.
Publicado: (2017)

Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c
por: Li, Yi-ming, et al.
Publicado: (2022)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
por: Xu, Gang, et al.
Publicado: (2017)

NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA
por: Ding, Hongda, et al.
Publicado: (2020)

Rcl1 suppresses tumor progression of hepatocellular carcinoma: a comprehensive analysis of bioinformatics and in vitro experiments
por: Jiaze, Yu, et al.
Publicado: (2022)

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice
por: Cash, J G, et al.
Publicado: (2016)

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
por: Chen, Jia-xin, et al.
Publicado: (2021)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression
por: Liu, Jian, et al.
Publicado: (2020)

S100A4 overexpression proves to be independent marker for breast cancer progression
por: Ismail, Nawfal I, et al.
Publicado: (2008)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1α
por: Chen, Qiguang, et al.
Publicado: (2019)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
por: Zhao, JiangSheng, et al.
Publicado: (2021)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Ferroptosis-related genes LPCAT3 and PGD are potential diagnostic biomarkers for osteoarthritis
por: Wang, Lufei, et al.
Publicado: (2023)

A cohesin‐associated gene score may predict immune checkpoint blockade in hepatocellular carcinoma
por: Liu, Cui‐Zhen, et al.
Publicado: (2022)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11
por: Yang, Lin, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways
por: Liu, Yufei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2jj4d3dnv4vqk4gsn60g295011